ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

$6.11
-0.11 (-1.69%)
As of Nov 15, 10:51 PM ET ·
Day Range $5.96 — $6.54
52W Range $4.07 — $44.40
Open$6.24
Previous Close$6.21
Day High$6.54
Day Low$5.96
52W High$44.40
52W Low$4.07
Volume—
Avg Volume154.8K
Market Cap15.81M
P/E Ratio—
EPS$-25.14
SectorBiotechnology

Analyst Ratings

Buy
15 analysts
9 Buy 6 Hold 0 Sell
Price Target +93.6% upside
Current
$6.11
Target
$11.82
$9.31 $11.82 avg $19.97

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 207.3K 786.7K 11.28M
Net Income -80,898,259 -276,312,839 2.04M
Profit Margin -39,009.5% -37,059.0% 18.1%
EBITDA -84,003,387 -302,858,511 2.88M
Free Cash Flow — — 1.40M
Rev Growth -73.7% -73.7% +22.8%
Debt/Equity 0.01 0.01 0.20

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $465.67 -0.30% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $538.60 -0.74% 33.9 134.82B
REGN Regeneron Pharmaceuticals $955.47 +0.45% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $165.04 +5.36% 7.7 20.98B

ATYR News

No news for ATYR yet

Quick Stats

Market Cap15.81M
P/E Ratio—
EPS$-25.14
Volume—
SectorBiotechnology